Pete De Spain | Vice President of Investor Relations |
Troy Wilson | President & Chief Executive Officer |
Marc Grasso | Chief Financial Officer & Chief Business Officer |
Jonathan Chang | SVB Leerink |
Pam Barendt | Cowen & Company |
Joe Pantginis | H.C. Wainwright |
Reni Benjamin | JMP Securities |
Good day, everyone. Welcome to the Kura Oncology 2Q 2020 Financial Results and Corporate Update Conference. Today's call is being recorded. At this time, I'd like to turn things over to Mr. Pete De Spain, Kura's Vice President of Investor Relations.